Everand Logo

Welcome to Everand!

  • STAT

    STAT+: Pharmalittle: Data confirm benefits and risks of Lilly Alzheimer’s drug; Medicare aims to pay hospitals to stockpile essential drugs

    by Ed Silverman Jul 18, 2023 1 minute
    Source: Alex Hogan/STAT

    Rise and shine, everyone, another busy day is on the way. We can tell because our shortest person has dashed off to a local educational institution in a hurry and the mascots are bounding. It begins at 1 p.m. ET. Meanwhile, we have collected a few items of interest that are displayed down below. We hope you have a smashing day and, as always, please do keep in touch. We treasure your tips and insights. …

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About Lilly Buying A Plant, A Pfizer Antibiotic, And More
    Eli Lilly agreed to acquire a manufacturing facility in Wisconsin from Nexus Pharmaceuticals to produce injectable medicines amid shortages of Mounjaro and Zepbound.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About An OptumRx Contract, 340B Dispute Resolution, And More
    Cardinal Health announced its pharmaceutical distribution contracts with UnitedHealth's OptumRx unit will not be renewed after they expire in June.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
    New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.

    Related Books & Audiobooks